Skip to main content

Advertisement

Table 1 Demographic and clinical characteristics of the two study groups

From: Young Hispanics at risk of type 2 diabetes display endothelial activation, subclinical inflammation and alterations of coagulation and fibrinolysis

  Risk group P
Control At risk
N= 19 17 -
Age (years) 28.3 ± 5.6 31.8 ± 5.5 0.07
Female sex (%) 47.3 58.8 0.59
Weight (Kg) 65.4 ± 12.1 87.5 ± 21.0 <0.001
Body mass Index (Kg/m2) 23.0 ± 2.0 32.2 ± 5.9 <0.001
Waist circumference (cm) 78.9 ± 7.5 99.1 ± 14.8 <0.001
Waist-to-hip ratio 0.82 ± 0.06 0.87 ± 0.07 0.014
Whole body fat (%) 24.2 ± 6.4 35.9 ± 7.1 <0.001
Trunk body fat (%) 23.0 ± 5.8 36.7 ± 7.8 <0.001
Systolic blood pressure (mmHg) 105.4 ± 13.7 112.4 ± 9.6 0.09
Diastolic blood pressure (mmHg) 67.9 ± 7.5 74.7 ± 9.7 0.025
Fasting plasma glucose (mmol/L) 4.70 ± 0.32 5.25 ± 0.43 <0.001
OGTT 2 h plasma glucose (mmol/L) 7.03 ± 2.16 8.23 ± 2.74 0.14
Impaired fasting glucose # (%) 0 (0) 2 (11.8) 0.12
Impaired glucose tolerance # (%) 0 (0) 5 (29.4) 0.011
Glycated hemoglobin A1c (%) 5.2 ± 0.2 5.2 ± 0.7 0.6
Total cholesterol (mmol/L) 4.45 ± 0.78 4.34 ± 1.04 0.74
Triglycerides (mmol/L) 0.84 ± 0.45 1.26 ± 0.64 0.026
HDL cholesterol (mmol/L) 1.23 ± 0.40 1.01 ± 0.25 0.067
LDL cholesterol (mmol/L) 2.87 ± 0.71 2.91 ± 1.06 0.91
Triglycerides/HDL cholesterol ratio 1.78 ± 1.2 3.15 ± 1.91 0.015
Plasma free fatty acids (mEq/L) 0.42 ± 0.16 0.58 ± 0.22 0.02
  1. Values are means (SD) unless indicated otherwise.